Comparative effectiveness of odronextamab (CD20 × CD3 bispecific antibody) versus real-world systemic therapies in relapsed/refractory follicular #lymphoma

Alt text: follow link to abstract
https://pubmed.ncbi.nlm.nih.gov/41736495/